DOJ Greenlights UnitedHealth/Amedisys With Divestitures
August 7, 2025
By: Ben Remaly
Global Competition Review
Axinn managing partner Jeny Maier was quoted in the Global Competition Review article, "DOJ Greenlights UnitedHealth/Amedisys With Divestitures."
Click here to access the publication. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
2026 Concurrences International Mergers Conference
Speaking Engagement
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
Fixing “Litigate the Fix”: Insights from the FTC’s Workshop
Axinn Viewpoints
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Axinn Recognized in 2026 IAM Patent 1000 for Patent Litigation Excellence
Awards & Recognitions
Intellectual Property
Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026
News
Litigation & Trials
Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion
Axinn Viewpoints
Intellectual Property
